Clinical trial design issues: Session 1
نویسندگان
چکیده
منابع مشابه
Statistical issues in clinical trial design.
This paper reviews some of the more salient recent developments in statistical aspects of clinical trial design methodology and suggests that more emphasis be placed on rigorous assessments of the new methodologies to place them in the context of existing methods, demonstrate their claimed advantages, and fully disclose their remaining limitations.
متن کاملTargeting targeted agents: open issues for clinical trial design
Molecularly targeted agents for the treatment of solid tumors had entered the market in the last 5 years, with a great impact upon both the scientific community and the society. Many randomized phase III trials conducted in recent years with new targeted agents, despite previous data coming from preclinical research and from phase II trials were often promising, have produced disappointingly ne...
متن کاملCurrent Therapeutic Cannabis Controversies and Clinical Trial Design Issues
This overview covers a wide range of cannabis topics, initially examining issues in dispensaries and self-administration, plus regulatory requirements for production of cannabis-based medicines, particularly the Food and Drug Administration "Botanical Guidance." The remainder pertains to various cannabis controversies that certainly require closer examination if the scientific, consumer, and go...
متن کاملCurrent issues in clinical trial design: superiority versus equivalency studies.
HISTORICALLY, the gold standard for drug approval by positive for the human immunodeficiency virus were the US Food and Drug Administration (FDA) has been randomized to the placebo group at a time when it was convincing evidence of efficacy in double-blind, placeknown that azidothymidine (AZT) prevented fetal trans bo-controlled, clinical trials. Because a placebo-conmission of the virus. On Fe...
متن کاملIssues in SMA clinical trial design. The International Coordinating Committee (ICC) for SMA Subcommittee on SMA Clinical Trial Design.
Advances in preclinical SMA research have identified several candidate treatments. Early clinical trials evaluating these medications are underway or in the planning stage. At the NINDS Workshop on SMA in September 2004 in Washington DC, discussions started within the international SMA community to identify features that should be common to SMA clinical trials [1]. Having a set of design featur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Cancer Supplements
سال: 2007
ISSN: 1359-6349
DOI: 10.1016/j.ejcsup.2007.09.023